Back to top

Image: Bigstock

Is a Surprise Coming for BridgeBio Pharma (BBIO) This Earnings Season?

Read MoreHide Full Article

Investors are always looking for stocks that are poised to beat at earnings season and BridgeBio Pharma, Inc. (BBIO - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because BridgeBio Pharma is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for BBIO in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at a loss of 85 cents per share for BBIO, compared to a broader Zacks Consensus Estimate of a loss of 86 cents per share. This suggests that analysts have very recently bumped up their estimates for BBIO, giving the stock a Zacks Earnings ESP of +0.78% heading into earnings season.

BridgeBio Pharma, Inc. Price and EPS Surprise

BridgeBio Pharma, Inc. Price and EPS Surprise

BridgeBio Pharma, Inc. price-eps-surprise | BridgeBio Pharma, Inc. Quote

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

Given that BBIO has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Clearly, recent earnings estimate revisions suggest that good things are ahead for BridgeBio Pharma, and that a beat might be in the cards for the upcoming report.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.9% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BridgeBio Pharma, Inc. (BBIO) - free report >>